just doing a bit of research into ARD & i notice that the 22 october, 2008 ....... Peter Strachen Research Report (on the website) ....... rated ARD higher than CCU based on insitu values. with CCU in strong demand atm, presumably for it silver deposit, could ARD also become a target for accumulation by an insto or investors ???
".....Argent’s closest peers include Malachite Resources, Silver Mines and Cobar Consolidated, which are working at the Conrad, Webbs and Wonawinto projects respectively. Both Silver Mines and Cobar Consolidated have run their cash down to about $1 million and while ore reserves of Silver Mines and Malachite have a similar insitu value per tonne to those of Argent, Silver Mines’ has a very small deposit and Cobar has a larger total insitu value, with a much lower insitu value per tonne. Malachite holds about $3 million of cash and its Conrad project has substantial size, with an insitu value per tonne which is in line with the values achieved at Argent’s projects.
Overall, when comparing Argent’s market capitalisation per dollar of resource value, with those of its direct peers involved in silver developments in NSW, the company appears to be significantly undervalued by comparison. Argent attracts a market cap of about 0.8% of the insitu value of its resources, while the close peer cohort companies are valued with a market capitalisation of between 1% and 3% of the insitu value of their resources. On the basis of this comparison, it appears that Argent has considerable potential to triple its value, so as to bring it into line with these peer companies".
- Forums
- ASX - By Stock
- ARD
- ccu running ard is not
ARD
argent minerals limited
Add to My Watchlist
4.76%
!
2.2¢

ccu running ard is not, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.2¢ |
Change
0.001(4.76%) |
Mkt cap ! $31.81M |
Open | High | Low | Value | Volume |
2.2¢ | 2.3¢ | 2.1¢ | $118.9K | 5.402M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
12 | 3581053 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 1844464 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 3509053 | 0.021 |
10 | 2973500 | 0.020 |
11 | 1934131 | 0.019 |
7 | 2985825 | 0.018 |
5 | 1272341 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.023 | 1720023 | 4 |
0.024 | 2890592 | 8 |
0.025 | 2272700 | 4 |
0.026 | 872300 | 5 |
0.027 | 2900071 | 10 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
ARD (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online